アレルギー診断市場：タイプ別、製品タイプ別、検査別、エンドユーザー別-2025-2030年の世界予測

アレルギー診断市場は、2023年に56億3,000万米ドルと評価され、2024年には59億4,000万米ドルに達すると予測され、CAGR 5.76％で成長し、2030年には83億5,000万米ドルに達すると予測されています。

アレルギー診断市場の範囲には、さまざまな検査・診断手順によるアレルギーの特定と理解が含まれます。花粉、食物、ペットのフケなど、さまざまなアレルゲンに対するアレルギーの検出を目的とした皮膚プリックテスト、血液検査、成分分解診断など、幅広い診断テストが含まれます。アレルギー診断の必要性は、環境やライフスタイルの変化により、世界中でアレルギー疾患が増加していることに起因しています。その用途は多岐にわたり、個人診断のための臨床現場、製薬研究、公衆衛生戦略などを包含しています。最終用途分野は主に病院、診断研究所、研究機関などです。市場に影響を与える主な成長要因としては、アレルギー発症率の上昇、診断技術の進歩、アレルギー疾患の早期発見と管理の重要性に対する意識の高まりなどが挙げられます。より正確で、費用対効果が高く、迅速な診断ソリューションの開発や、十分なサービスを受けていない地域へのアレルギー診断サービスの拡大など、ビジネスチャンスは豊富にあります。研究機関と市場プレイヤーの戦略的提携により、市場規模はさらに拡大する可能性があります。しかし、市場は、厳しい規制要件、高度な診断検査のコスト高、新興国地域での認知度の低さなどの課題に直面しています。技術革新の余地がある分野としては、ナノベースの診断ツールや、特定のアレルゲン性タンパク質を正確に同定するゲノムベースの検査法の進歩が挙げられます。技術革新と世界のアレルギーの蔓延により市場は成長傾向にあるため、企業は個別化アレルギー診断に焦点を当てた研究開発に投資することが推奨されます。そうすることで、企業は競争優位性を高め、アンメットニーズに対応し、患者転帰の改善と市場プレゼンス拡大への道を開くことができます。

市場力学：急速に進化するアレルギー診断市場の主要市場インサイトを公開

アレルギー診断市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界のアレルギー患者の増加と気象パターンの変化
  • アレルギーに対する認識と、診断ソリューションの展開を支援する政府の取り組み
  • アレルギー管理ソリューションを提供する薬局や診断施設の拡大
• 市場抑制要因
  • 特定のアレルギー診断ソリューションおよびツールの製品回収の発生
• 市場機会
  • アレルギー診断ソリューションの精度と感度を向上させるための継続的な技術革新
  • デジタルおよび遠隔医療プラットフォームの拡大と個別化診断ソリューションへの嗜好性
• 市場の課題
  • アレルギー診断ソリューションに関連する結果のばらつきと感度の低さの問題

ポーターのファイブフォース：アレルギー診断市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、アレルギー診断市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：アレルギー診断市場における外部からの影響の把握

外部マクロ環境要因は、アレルギー診断市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析アレルギー診断市場における競合情勢の把握

アレルギー診断市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスアレルギー診断市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、アレルギー診断市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨アレルギー診断市場における成功への道筋を描く

アレルギー診断市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中でアレルギー症例の増加と気象パターンの変化
    • アレルギーに関する認識と診断ソリューションの導入を支援する政府の取り組み
    • アレルギー管理ソリューションを提供する薬局および診断施設の拡大
  • 抑制要因
    • 特定のアレルギー診断ソリューションおよびツールの製品リコールの発生
  • 機会
    • アレルギー診断ソリューションの精度と感度を向上させるための継続的な技術革新
    • デジタルおよび遠隔医療プラットフォームの拡大とパーソナライズされた診断ソリューションの選好
  • 課題
    • アレルギー診断ソリューションに関連する結果のばらつきと感度の低さの問題
• 市場セグメンテーション分析
  • タイプ：吸入アレルゲンが環境中に遍在し、頻繁に曝露される可能性
  • エンドユーザー：ヘルスケアの近代化に向けた政府の取り組みによって支えられた、世界中の診断ラボの拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 アレルギー診断市場：タイプ別

• 薬物アレルゲン
• 食品アレルゲン
• 吸入アレルゲン

第7章 アレルギー診断市場：製品タイプ別

• アッセイキット
• 消耗品
• 機器
  • 免疫測定分析装置
  • ルミノメーター

第8章 アレルギー診断市場テスト別

• 体外試験
• 生体内テスト

第9章 アレルギー診断市場：エンドユーザー別

• 学術調査機関
• 診断検査室
• 病院内検査室

第10章 南北アメリカのアレルギー診断市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のアレルギー診断市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのアレルギー診断市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • AllerGenisによる牛乳と管理の革命的な進歩
  • メトロポリスヘルスケアによるAI搭載コンポーネント解決診断（CRD）のイントロダクション
  • AIによるDr.Dang's LabによるAllergynius Dxのイントロダクションアレルギー診断
• 戦略分析と提言

企業一覧

• ALK-Abello A/S
• Allergy Therapeutics PLC
• Astra Biotech GmbH
• Bausch & Lomb Incorporated
• Biomerieux SA
• Danaher Corporation
• Dr. Fooke-Achterrath Laboratorien GmbH
• DST Diagnostische Systeme & Technologien GmbH
• Erba Group by Transasia Bio-Medicals Ltd.
• Eurofins Scientific SE
• EUROIMMUN Medizinische Labordiagnostika AG
• HAL Allergy B.V.
• Hitachi, Ltd.
• HOB Biotech Group Corp., Ltd.
• HollisterStier by Jubilant Life Sciences Limited
• HYCOR Biomedical LLC
• Lincoln Diagnostics, Inc.
• Minaris Medical America, Inc.
• Neogen Corporation
• Omega Diagnostics Group PLC
• R-Biopharm AG
• Romer Labs Division Holding GmbH by Royal DSM
• ROXALL Medizin GmbH
• Siemens AG
• Stallergenes Greer International AG
• Tecan Trading AG
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. ALLERGY DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. ALLERGY DIAGNOSTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ALLERGY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ALLERGY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ALLERGY DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ALLERGY DIAGNOSTICS MARKET DYNAMICS
• TABLE 7. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY DRUG ALLERGEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY FOOD ALLERGEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY INHALED ALLERGEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY IN-VITRO TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY IN-VIVO TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 44. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 45. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 71. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 72. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 76. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 77. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 159. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 162. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 163. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 179. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 182. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 183. POLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 184. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 186. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 187. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 188. QATAR ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. ALLERGY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 235. ALLERGY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Allergy Diagnostics Market was valued at USD 5.63 billion in 2023, expected to reach USD 5.94 billion in 2024, and is projected to grow at a CAGR of 5.76%, to USD 8.35 billion by 2030.

The scope of the allergy diagnostics market involves the identification and understanding of allergies through various testing and diagnostic procedures. It encompasses a wide range of diagnostic tests such as skin prick tests, blood tests, and component-resolved diagnostics aimed at detecting allergies to a variety of allergens including pollen, food, and pet dander. The necessity of allergy diagnostics stems from the increasing prevalence of allergic diseases worldwide, driven by environmental and lifestyle changes. Its applications are expansive, encompassing clinical settings for individual diagnosis, pharmaceutical research, and public health strategies. End-use sectors primarily include hospitals, diagnostic laboratories, and research institutes. Key growth factors influencing the market include the rising incidence of allergies, advancements in diagnostic technology, and increasing awareness of the importance of early detection and management of allergic conditions. Opportunities abound in the development of more accurate, cost-effective, and rapid diagnostic solutions, as well as in expanding allergy diagnostic services to underserved regions. Strategic collaborations among research institutes and market players could further amplify market reach. However, the market faces challenges such as stringent regulatory requirements, high costs of advanced diagnostic tests, and limited awareness in developing regions. Areas ripe for innovation include the advancement of nano-based diagnostic tools and genomic-based testing methods that offer precise identification of specific allergenic proteins. As the nature of the market leans towards growth due to technological innovation and increasing global allergy prevalence, businesses are advised to invest in research and development focused on personalized allergy diagnostics. By doing so, firms can enhance their competitive advantage and address unmet needs within allergy diagnostics, paving the way for improved patient outcomes and expanded market presence.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Allergy Diagnostics Market

The Allergy Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of allergy cases and changes in weather patterns across the world
  • Awareness regarding allergies and government initiatives supporting the deployment of diagnostics solutions
  • Expansion of pharmacies and diagnostics facilities providing allergy management solutions
• Market Restraints
  • Incidences of product recall of certain allergy diagnostics solutions and tools
• Market Opportunities
  • Ongoing technological innovations to improve the accuracy and sensitivity of allergy diagnostics solutions
  • Expansion of digital and telehealth platforms and preference for personalized diagnostic solutions
• Market Challenges
  • Variability in results and low sensitivity issues associated with allergy diagnostics solutions

Porter's Five Forces: A Strategic Tool for Navigating the Allergy Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Allergy Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Allergy Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Allergy Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Allergy Diagnostics Market

A detailed market share analysis in the Allergy Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Allergy Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Allergy Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Allergy Diagnostics Market

A strategic analysis of the Allergy Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Allergy Diagnostics Market, highlighting leading vendors and their innovative profiles. These include ALK-Abello A/S, Allergy Therapeutics PLC, Astra Biotech GmbH, Bausch & Lomb Incorporated, Biomerieux SA, Danaher Corporation, Dr. Fooke-Achterrath Laboratorien GmbH, DST Diagnostische Systeme & Technologien GmbH, Erba Group by Transasia Bio-Medicals Ltd., Eurofins Scientific SE, EUROIMMUN Medizinische Labordiagnostika AG, HAL Allergy B.V., Hitachi, Ltd., HOB Biotech Group Corp., Ltd., HollisterStier by Jubilant Life Sciences Limited, HYCOR Biomedical LLC, Lincoln Diagnostics, Inc., Minaris Medical America, Inc., Neogen Corporation, Omega Diagnostics Group PLC, R-Biopharm AG, Romer Labs Division Holding GmbH by Royal DSM, ROXALL Medizin GmbH, Siemens AG, Stallergenes Greer International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Allergy Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Drug Allergen, Food Allergen, and Inhaled Allergen.
• Based on Product Type, market is studied across Assay Kits, Consumables, and Instruments. The Instruments is further studied across Immunoassay Analyzers and Luminometers.
• Based on Test, market is studied across In-Vitro Tests and In-Vivo Tests.
• Based on End User, market is studied across Academic Research Institutes, Diagnostic Laboratories, and Hospital-Based Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of allergy cases and changes in weather patterns across the world
    • 5.1.1.2. Awareness regarding allergies and government initiatives supporting the deployment of diagnostics solutions
    • 5.1.1.3. Expansion of pharmacies and diagnostics facilities providing allergy management solutions
  • 5.1.2. Restraints
    • 5.1.2.1. Incidences of product recall of certain allergy diagnostics solutions and tools
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing technological innovations to improve the accuracy and sensitivity of allergy diagnostics solutions
    • 5.1.3.2. Expansion of digital and telehealth platforms and preference for personalized diagnostic solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Variability in results and low sensitivity issues associated with allergy diagnostics solutions
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Ubiquitous nature of inhaled allergens in the environment and chances of frequent exposure
  • 5.2.2. End User: Expansion of diagnostic laboratories across the world supported by government initiatives for modernizing healthcare
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Allergy Diagnostics Market, by Type

• 6.1. Introduction
• 6.2. Drug Allergen
• 6.3. Food Allergen
• 6.4. Inhaled Allergen

7. Allergy Diagnostics Market, by Product Type

• 7.1. Introduction
• 7.2. Assay Kits
• 7.3. Consumables
• 7.4. Instruments
  • 7.4.1. Immunoassay Analyzers
  • 7.4.2. Luminometers

8. Allergy Diagnostics Market, by Test

• 8.1. Introduction
• 8.2. In-Vitro Tests
• 8.3. In-Vivo Tests

9. Allergy Diagnostics Market, by End User

• 9.1. Introduction
• 9.2. Academic Research Institutes
• 9.3. Diagnostic Laboratories
• 9.4. Hospital-Based Laboratories

10. Americas Allergy Diagnostics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Allergy Diagnostics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Allergy Diagnostics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Revolutionary Advancements in Milk Allergy Diagnostics and Management Presented by AllerGenis
  • 13.3.2. Metropolis Healthcare's Introduction of AI-Powered Component Resolved Diagnostics (CRD)
  • 13.3.3. Introduction of Allergynius Dx by Dr. Dang's Lab For Allergy Diagnostics through AI
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ALK-Abello A/S
• 2. Allergy Therapeutics PLC
• 3. Astra Biotech GmbH
• 4. Bausch & Lomb Incorporated
• 5. Biomerieux SA
• 6. Danaher Corporation
• 7. Dr. Fooke-Achterrath Laboratorien GmbH
• 8. DST Diagnostische Systeme & Technologien GmbH
• 9. Erba Group by Transasia Bio-Medicals Ltd.
• 10. Eurofins Scientific SE
• 11. EUROIMMUN Medizinische Labordiagnostika AG
• 12. HAL Allergy B.V.
• 13. Hitachi, Ltd.
• 14. HOB Biotech Group Corp., Ltd.
• 15. HollisterStier by Jubilant Life Sciences Limited
• 16. HYCOR Biomedical LLC
• 17. Lincoln Diagnostics, Inc.
• 18. Minaris Medical America, Inc.
• 19. Neogen Corporation
• 20. Omega Diagnostics Group PLC
• 21. R-Biopharm AG
• 22. Romer Labs Division Holding GmbH by Royal DSM
• 23. ROXALL Medizin GmbH
• 24. Siemens AG
• 25. Stallergenes Greer International AG
• 26. Tecan Trading AG
• 27. Thermo Fisher Scientific Inc.